Crossmark

Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study

Crossref DOI link: https://doi.org/10.1016/j.jsps.2023.101736

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Saad Alshahrani, Abdulaziz

Mohammad, Danah

attieh Alzahrani, Mohammad

Narula, Neeraj
License Information

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2023-07-30
More Information

This article is maintained by: Elsevier

Article Title: Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study

Journal Title: Saudi Pharmaceutical Journal

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jsps.2023.101736

Content Type: article

Copyright: © 2023 The Authors. Published by Elsevier B.V. on behalf of King Saud University.

Document is current

Any future updates will be listed below